STINGENI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 563
EU - Europa 462
AS - Asia 67
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
OC - Oceania 1
Totale 1.159
Nazione #
US - Stati Uniti d'America 559
IE - Irlanda 196
RU - Federazione Russa 71
CI - Costa d'Avorio 59
FI - Finlandia 41
UA - Ucraina 39
IT - Italia 35
SE - Svezia 31
CN - Cina 29
SG - Singapore 25
DE - Germania 15
GB - Regno Unito 10
AT - Austria 8
BE - Belgio 7
CA - Canada 4
FR - Francia 4
IN - India 4
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
EU - Europa 2
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
LT - Lituania 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
DK - Danimarca 1
MY - Malesia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TW - Taiwan 1
Totale 1.159
Città #
Chandler 205
Dublin 196
Abidjan 59
Jacksonville 56
Helsinki 41
New York 36
San Mateo 21
Princeton 20
Wilmington 20
Singapore 12
Ann Arbor 11
Jinan 8
Vienna 8
Brussels 7
Ashburn 4
Frankfurt am Main 4
Beijing 3
Dallas 3
London 3
Molise 3
Rome 3
San Francisco 3
Toronto 3
Borås 2
Hangzhou 2
Hebei 2
Nanchang 2
Naples 2
Shanghai 2
Auckland 1
Bangalore 1
Boardman 1
Haikou 1
Harbin 1
Hong Kong 1
Huizen 1
Kazan 1
Kursk 1
La Paz 1
Los Angeles 1
Monmouth Junction 1
Mumbai 1
Nanjing 1
Ningbo 1
Norwalk 1
Ottawa 1
Redwood City 1
Rockville 1
Sao Goncalo 1
Seattle 1
Shenyang 1
Siena 1
Taizhou 1
Woodbridge 1
Wuxi 1
Zhengzhou 1
Totale 768
Nome #
Efficacia e tollerabilità di una crema liporestitutiva e lenitiva in pazienti con xerosi cutanea, dermatite atopica e eczema xerotico 102
An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease 97
Dupilumab and COVID-19: what should we expect? 69
Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study 68
Drug-induced aseptic meningitis to ibuprofen: The first case confirmed by positive patch test 61
Four-week urticaria activity score-7 as a useful patient-reported outcome to assess chronic spontaneous urticaria: A multicentre study evaluation of adherence and patients’ perspective 61
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 61
The role of occupational dermatology in the COVID-19 outbreak 60
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study 59
Contact sensitivity to electrocardiogram electrodes due to acrylic acid: A rare cause of medical device allergy 57
Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults 54
Profile of baricitinib and its potential in the treatment of moderate to severe atopic dermatitis: A short review on the emerging clinical evidence 53
Contact allergy to 3-dimethylaminopropylamine in 5140 consecutive Italian patients: A one-year retrospective multicenter SIDAPA study 52
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients 50
Urticaria: Recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology 49
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): a real-life retrospective cohort multicentre study on 438 subjects with chronic hand eczema 49
Skin tests in the diagnosis of adverse drug reactions 49
Patch testing with textile dye mix in Italy: A 2-year multicenter SIDAPA study 48
Prevalence of Chronic Inducible Urticaria in Elderly Patients 48
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 41
Totale 1.188
Categoria #
all - tutte 6.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 3 0 2 4 2 4 1 2
2020/2021141 12 14 0 35 14 3 17 1 20 1 24 0
2021/2022114 3 21 6 2 10 11 0 12 20 12 7 10
2022/2023591 61 47 9 73 24 52 0 33 251 25 8 8
2023/2024111 32 5 12 4 6 40 0 1 1 0 0 10
2024/2025189 65 9 43 4 68 0 0 0 0 0 0 0
Totale 1.188